Autologous Rectus Sheath Fascia Versus Midurethral Transobturator Tension Free Vaginal

Sponsor
sarah mohamed hassan (Other)
Overall Status
Unknown status
CT.gov ID
NCT03473041
Collaborator
(none)
140
1
2
18
7.8

Study Details

Study Description

Brief Summary

a hybrid sling formed of a central part of autologus rectus sheath (2×6 cm) and two arms of polypropylene mesh (2×10cm) versus transobturator tension free vaginal tape(TVT-O)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hybrid sling
  • Procedure: TVT-O
Phase 3

Detailed Description

a surgeon tailored hybrid sling formed of a central part of autologus rectus sheath (2×6 cm) and two arms of polypropylene mesh (2×10cm) is used for treatment of urinary stree incontinence and its efficacy is compared to transobturator tension free vaginal tape (TVT-O) conventional mid urethral sling

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Surgeon Tailored Hybrid Autologus Rectus Sheath Fascia Versus Midurethral Transobturator Tension Free Vaginal Tape For Treatment Of Stress Urinary Incontinence
Anticipated Study Start Date :
Mar 1, 2018
Anticipated Primary Completion Date :
Sep 1, 2019
Anticipated Study Completion Date :
Sep 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hybrid sling

70 patients with stress urinary incontinence treated with surgeon tailored hybrid sling

Procedure: Hybrid sling
sling formed of surgeon tailored autologous rectus sheath and polypropylene arms

Active Comparator: TVT-O

70 patients with stress urinary incontinence treated with conventional TVT-O

Procedure: TVT-O
midurethral transobturator vaginal tape

Outcome Measures

Primary Outcome Measures

  1. cure rate [1 year follow up]

    negative cough stress test

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • stress urinary incontinence
Exclusion Criteria:
  • previous surgery for stress incontinence

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr El Ainiy Hospital Cairo Egypt 11562

Sponsors and Collaborators

  • sarah mohamed hassan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
sarah mohamed hassan, lecturer of obstetrics and gynecology, Kasr El Aini Hospital
ClinicalTrials.gov Identifier:
NCT03473041
Other Study ID Numbers:
  • 783
First Posted:
Mar 21, 2018
Last Update Posted:
Mar 21, 2018
Last Verified:
Mar 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by sarah mohamed hassan, lecturer of obstetrics and gynecology, Kasr El Aini Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2018